Gene expression profiles linked to AT1 angiotensin receptors in the kidney

Physiological Genomics

Volumn 42 A, Issue 3, 2010, Pages 211-218

  Makhanova, Natalia A ^a   Crowley, Steven D ^a   Griffiths, Robert C ^a   Coffman, Thomas M ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Hypertension; Microarray analysis; Oxidative stress; Transgenic mice

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; GLUTATHIONE SYNTHASE; RNA; SUPEROXIDE DISMUTASE;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD PRESSURE REGULATION; CELL PROLIFERATION; CLINICAL PATHWAY; CONTROLLED STUDY; GENE EXPRESSION; GENOME; GLUTATHIONE METABOLISM; IMMUNE RESPONSE; ION TRANSPORT; KIDNEY; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RNA ANALYSIS; UPREGULATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HYPERTENSION; IMMEDIATE-EARLY PROTEINS; IMMUNOBLOTTING; INFUSIONS, SUBCUTANEOUS; KIDNEY; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, ANGIOTENSIN, TYPE 1; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASOCONSTRICTOR AGENTS;

MUS; MUS MUSCULUS;

EID: 78649758730     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00063.2010     Document Type: Article

References (42)

1. Abraham NG, Asija A, Drummond G, Peterson S. Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther 7: 89-108, 2007. (Pubitemid 46681767)
2. Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 41: 163-181, 2000. (Pubitemid 30117856)
3. 2 receptors. Kidney Int 54: S95-S99, 1998.
4. Coffman TM, Crowley SD. Kidney in hypertension: guyton redux. Hypertension 51: 811-816, 2008.
5. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 103: 17985-17990, 2006.
6. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 115: 1092-1099, 2005.
7. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
8. Di Cunto F, Calautti E, Hsiao J, Ong L, Topley G, Turco E, Dotto GP. Citron rho-interacting kinase, a novel tissue-specific ser/thr kinase encompassing the Rho-Rac-binding protein Citron. J Biol Chem 273: 29706-29711, 1998.
9. Doan TN, Ali MS, Bernstein KE. Tyrosine kinase activation by the angiotensin II receptor in the absence of calcium signaling. J Biol Chem 276: 20954-20958, 2001. (Pubitemid 37413075)
10. Donowitz M, Li X. Regulatory binding partners and complexes of NHE3. Physiol Rev 87: 825-872, 2007. (Pubitemid 47086280)
11. Du Cheyron D, Chalumeau C, Defontaine N, Klein C, Kellermann O, Paillard M, Poggioli J. Angiotensin II stimulates NHE3 activity by exocytic insertion of the transporter: role of PI 3-kinase. Kidney Int 64: 939-949, 2003.
12. Fabia MJ, Abdilla N, Oltra R, Fernandez C, Redon J. Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens 25: 1327-1336, 2007.
13. Féraille E, Doucet A. Sodium-potassium-adenosinetriphosphatase- dependent sodium transport in the kidney: hormonal control. Physiol Rev 81: 345-418, 2001. (Pubitemid 32096179)
14. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, Haystead TA, Donoghue M, Breitbart RE, Acton SL, Rockman HA, Coffman TM. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 116: 2218-2225, 2006. (Pubitemid 44162331)
15. Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 51-61, 2003.
16. Holla VR, Adas F, Imig JD, Zhao X, Price E Jr, Olsen N, Kovacs WJ, Magnuson MA, Keeney DS, Breyer MD, Falck JR, Waterman MR, Capdevila JH. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci USA 98: 5211-5216, 2001.
17. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92: 3521-3525, 1995.
18. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43: 1126-1132, 2004.
19. + exchanger NHE3 at PKA consensus sites. Am J Physiol Renal Physiol 289: F249-F258, 2005.
20. Le TH, Crowley SD, Gurley SB, Coffman TM. The renin-angiotensin system. In: Seldin and Giebisch's The Kidney: Physiology & Pathophysiology 1-2 (vol. 1), edited by Alpern RJ, Hebert SC. Burlington, MA: Elsevier, 2007, p. 343-357.
21. Le TH, Fogo AB, Salzler HR, Vinogradova T, Oliverio MI, Marchuk DA, Coffman TM. Modifier locus on mouse chromosome 3 for renal vascular pathology in AT1A receptor-deficiency. Hypertension 43: 445-451, 2004. (Pubitemid 38174152)
22. + channels by aldosterone: role of Sgk1. Clin Exp Pharmacol Physiol 35: 235-241, 2008.
23. Loffing J, Flores SY, Staub O. Sgk kinases and their role in epithelial transport. Annu Rev Physiol 68: 461-490, 2006.
24. Matsusaka T, Nishimura H, Utsunomiya H, Kakuchi J, Niimura F, Inagami T, Fogo A, Ichikawa I. Chimeric mice carrying 'regional' targeted deletion of the angiotensin type 1A receptor gene. Evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J Clin Invest 98: 1867-1877, 1996.
25. McGiff JC, Quilley J. 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 10: 231-237, 2001.
26. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97, 2007.
27. Miura S, Zhang J, Matsuo Y, Saku K, Karnik. Activation of extracellular signal-activated kinase by angiotensin II-induced Gq-independent epidermal growth factor receptor transactivation. Hypertens Res 27: 765-770, 2004.
28. Oliverio MI, Best CF, Kim HS, Arendshorst WJ, Smithies O, Coffman TM. Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation. Am J Physiol Renal Physiol 272: F515-F520, 1997. (Pubitemid 27382231)
29. Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O, Coffman TM. Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol Renal Physiol 274: F43-F50, 1998. (Pubitemid 28133972)
30. Ouyang X, Le TH, Roncal C, Gersch C, Herrera-Acosta J, Rodriguez-Iturbe B, Coffman TM, Johnson RJ, Mu W. Th1 inflammatory response with altered expression of profibrotic and vasoactive mediators in AT1A and AT1B double-knockout mice. Am J Physiol Renal Physiol 289: F902-F910, 2005.
31. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol 284: R893-R912, 2003.
32. Riquier-Brison AD, Leong PK, Pihakaski-Maunsbach K, McDonough AA. Angiotensin II stimulates trafficking of NHE3, NaPi2, and associated proteins into the proximal tubule microvilli. Am J Physiol Renal Physiol 298: F177-F186, 2010.
33. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
34. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD. Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice. Hypertension 43: 1074-1079, 2004. (Pubitemid 38579916)
35. - cotransporter to apical membrane. Am J Physiol Renal Physiol 293: F662-F669, 2007.
36. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ. Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 185: 253-259, 1992.
37. Schiff D, Purow BW. Neuro-oncology: isocitrate dehydrogenase mutations in low-grade gliomas. Nat Rev Neurol 5: 303-304, 2009.
38. Steckelings UM, Kaschina E, Unger T. The AT2 receptor-a matter of love and hate. Peptides 26: 1401-1409, 2005. (Pubitemid 41021474)
39. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000.
40. Widder JD, Guzik TJ, Mueller CF, Clempus RE, Schmidt HH, Dikalov SI, Griendling KK, Jones DP, Harrison DG. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. Arterioscler Thromb Vasc Biol 27: 762-768, 2007.
41. Wolf G. Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis. Antioxid Redox Signal 7: 1337-1345, 2005. (Pubitemid 41232531)
42. Xue B, Pamidimukkala J, Hay M. Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol 288: H2177-H2184, 2005.